Telaprevir

Use the mouse wheel or two fingers (on touchscreens) to zoom in and out of the map.

Map view:

Zoom: 100%

More settings

Connection length 100% Label size 100% Node size 100% Line width 100% Label width 100%

Export map as:

Telaprevir topic overview

The analysis highlights Research and Standards as prominent areas in the source structure around Telaprevir.

Related topics: 22
Source areas: 4
Connected nodes: 26
Extracted relationships: 61
Concept neighborhoods: 14
Bridge connections: 26

What this topic covers Research coverage

Source areas are shown by the number of related topics found in each part of the analysis. Use smaller areas too: they can reveal specialized angles and content gaps.

Overview · 9 topics

Clinical trials and approvals · 7 topics

Adverse effects · 4 topics

Research · 2 topics

Smaller areas are not necessarily less important. They contain fewer connections in this analysis and can be useful for finding specialized angles or coverage gaps.

Key facts & relationships

High-confidence facts extracted from structured source data. Use them as anchors for further research.

3D model (JSmol): Interactive image
AHFS/Drugs.com: Consumer Drug Information
ATC code: J05AP02 (WHO)
CAS Number: 402957-28-2 N
ChEBI: CHEBI:68595 N
ChEMBL: ChEMBL231813 Y

Explore all related topics Closing gaps

Browse the complete topic structure, not only the most central items. Less prominent entities and concepts can reveal missing angles, specialized context and useful research gaps. Each item opens a new analysis centered on that subject.

Overview

Hepatitis C
Vertex Pharmaceuticals
Johnson & Johnson
Antiviral drugs Antiviral drug
Protease inhibitors Protease inhibitor (pharmacology)
NS3/4A serine protease NS3 (HCV)
Genotype
Pegylated interferon
Ribavirin

Clinical trials and approvals

Randomized controlled trial
Peginterferon alfa-2a
FDA
Boceprevir
Single-nucleotide polymorphisms Single-nucleotide polymorphism
Rs8099917 Rs8099917?action=edit&redlink=1
Rs12979860 Rs12979860?action=edit&redlink=1

Adverse effects

Research

Advanced semantic analysis

Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.

How Telaprevir connects Entity context

The extracted context around Telaprevir shows recurring relationship patterns in the source. For example, Telaprevir → ADVANCE, Committee, FDA Antiviral Drugs Advisory, HCV, III ADVANCE, ILLUMINATE, In, May, Merck's, On April, PROVE3, REALIZE, SVR, The, This, United States Another extracted example is Telaprevir → After, Drug Administration, FDA, Grade, Incivek, On December, The, The FDA, US, US Food, Vertex. Use these groups to spot repeated connection types before inspecting the individual relationships.

Top relations

related to Clinical trials and approvals · 16

Telaprevir → ADVANCE, Committee, FDA Antiviral Drugs Advisory, HCV, III ADVANCE, ILLUMINATE, In, May, Merck's, On April, PROVE3, REALIZE, SVR, The, This, United States

has effect · 11

Telaprevir → After, Drug Administration, FDA, Grade, Incivek, On December, The, The FDA, US, US Food, Vertex

related to Availability · 4

Telaprevir → Incivek, On August, The, Vertex Pharmaceuticals

related to Research · 4

Telaprevir → AFM, D68, Since, Studies

3D model (JSmol) · 1

Telaprevir → Interactive image

AHFS/Drugs.com · 1

Telaprevir → Consumer Drug Information

ATC code · 1

Telaprevir → J05AP02 (WHO)

CAS Number · 1

Telaprevir → 402957-28-2 N

ChEBI · 1

Telaprevir → CHEBI:68595 N

ChEMBL · 1

Telaprevir → ChEMBL231813 Y

Important terminology

Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.

Important terminology

hepatitis svr therapy ribavirin patients treatment genotype incivek drug vertex viral fda drugs trial peginterferon response antiviral use standard protease

Telaprevir relationships Subject–Predicate–Object triples

TTTA extracted 61 structured relationships around Telaprevir. Examples in this analysis include Telaprevir → 3D model (JSmol) → Interactive image and Telaprevir → AHFS/Drugs.com → Consumer Drug Information. The table shows each extracted connection, where it came from and its confidence.

Subject	Predicate	Object	Confidence	Src
Telaprevir	3D model (JSmol)	Interactive image	1.00	infobox
Telaprevir	AHFS/Drugs.com	Consumer Drug Information	1.00	infobox
Telaprevir	ATC code	J05AP02 (WHO)	1.00	infobox
Telaprevir	CAS Number	402957-28-2 N	1.00	infobox
Telaprevir	ChEBI	CHEBI:68595 N	1.00	infobox
Telaprevir	ChEMBL	ChEMBL231813 Y	1.00	infobox
Telaprevir	ChemSpider	2279948 Y	1.00	infobox
Telaprevir	CompTox Dashboard (EPA)	DTXSID40193304	1.00	infobox
Telaprevir	DrugBank	DB05521 N	1.00	infobox
Telaprevir	ECHA InfoCard	100.129.857	1.00	infobox
Telaprevir	Elimination half-life	9–11 hours	1.00	infobox
Telaprevir	Excretion	90% (bile), 9% (exhaled air), 1% (urine)	1.00	infobox
Telaprevir	Formula	C36H53N7O6	1.00	infobox
Telaprevir	IUPHAR/BPS	7871	1.00	infobox
Telaprevir	KEGG	D09012 Y	1.00	infobox
Telaprevir	Legal status	US: ℞-only	1.00	infobox
Telaprevir	License data	US FDA: Telaprevir	1.00	infobox
Telaprevir	MedlinePlus	a611038	1.00	infobox
Telaprevir	Metabolism	extensive hepatic	1.00	infobox
Telaprevir	Molar mass	679.863 g·mol−1	1.00	infobox
Telaprevir	NIAID ChemDB	213006	1.00	infobox
Telaprevir	Protein binding	59–76%	1.00	infobox
Telaprevir	PubChem CID	3010818	1.00	infobox
Telaprevir	Routes of administration	Oral	1.00	infobox
Telaprevir	Trade names	Incivek, Incivo	1.00	infobox
Telaprevir	UNII	655M5O3W0U	1.00	infobox

Related concept clusters Concept neighborhoods

The concept neighborhoods around Telaprevir bring nearby vocabulary together. In this analysis, examples include Hepatitis, Ribavirin and Treatment. Use the clusters to find adjacent concepts and terminology that may deserve separate research.

Telaprevir
- Hepatitis
- Ribavirin
- Treatment
- Patients
- Svr
- Fda
- Peginterferon
- Trial
- Vertex
- Alfa-2a
- Standard
- Us
telaprevir
- Hepatitis
- Ribavirin
- Treatment
- Patients
- Svr
- Fda
- Peginterferon
- Trial
- Vertex
- Alfa-2a
- Standard
- Us
hepatitis c
- Telaprevir
- Vertex
- Viral
- Incivek
- Treatment
- Therapy
- Pharmaceuticals
- Virus
- Sustained
- Use
- Drugs
- Fda
antiviral drugs
- Fda
- Drugs
- Us
- Peginterferon
- Incivek
- Protease
- Ribavirin
- Treatment
- Patients
- Committee
- Incivo
- Names
fda
- Us
- Incivek
- Treatment
- People
- Patients
- Peginterferon
- Vertex
- Ribavirin
- Telaprevir
- Incivo
- Names
- Alfa-2a
adverse effects
- Incivo
- Names
- Virus
- Alfa-2a
- Standard
- Sustained
- Us
- Drugs
- Fda
- Peginterferon
- Response
- Trial
peginterferon alfa-2a
- Alfa-2a
- Peginterferon
- Ribavirin
- Treatment
- Us
- Svr
- Incivo
- Names
- Patients
- Telaprevir
- Standard
- Sustained
vertex pharmaceuticals
- Incivek
- Brand
- Drug
- Pharmaceuticals
- Vertex
- Treatment
- Us
- Fda
- Hepatitis
- Patients
- Telaprevir
- Incivo

Connections between topic areas Semantic bridges

For Telaprevir, one of the stronger structural bridges in this analysis connects Telaprevir with Overview. Bridges highlight paths between different parts of the map and can reveal research angles that are easy to miss in a flat list.

Min side: 3

Telaprevir — Overview · splits 17 ⟂ 10

Telaprevir — Clinical trials and approvals · splits 19 ⟂ 8

Telaprevir — Adverse effects · splits 22 ⟂ 5

Telaprevir — Research · splits 24 ⟂ 3

Map overview Semantic statistics

Telaprevir

Nodes27

Edges26

Triples61

Avg. degree1.93

Density0.074074

Components1

Source & methodology

TTTA analyzes the structure around Telaprevir to surface related topics, entities, relationships, concept neighborhoods and bridge connections. Use the map to explore areas such as Research & Standards, including less central topics that may reveal useful research gaps. Automatically extracted connections are research leads rather than rewritten encyclopedia content.

Source: Wikipedia — Telaprevir · EN edition · Analysis: TopicsToTalkAbout